SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-044072
Filing Date
2024-05-16
Accepted
2024-05-16 10:26:45
Documents
1
Period of Report
2024-04-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4824
  Complete submission text file 0001213900-24-044072.txt   6800
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9559 COLLINS AVE, APT 1099S MIAMI FL 33154
Business Address 9559 COLLINS AVE, APT 1099S MIAMI FL 33154 845-570-1240
ALPHA PHARMA Investments LLC (Reporting) CIK: 0002018003 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39114 | Film No.: 24953903

Mailing Address 9559 COLLINS AVENUE #1009S MIAMI FL 33154
Business Address
Soffer Rochel (Reporting) CIK: 0002023129 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39114 | Film No.: 24953904